13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
Since the UK's referendum on EU membership in June 2016, there has been significant uncertainty over...
Read More >
There is no change in the two key issues that have been causing concern to those involved in real es...
Read More >
New Jersey Governor Phil Murphy signed six bills into law on January 20, all targeting the use of in...
Read More >
On 11 February 2020, the World Health Organisation renamed the virus COVID-19, (apparently in accord...
Read More >
Here are five hidden risks common to many workplaces which employers should prioritise to save your ...
Read More >
The U.S. District Court for the Northern District of Alabama has compelled arbitration despite a for...
Read More >